Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

Table 6

Multifactorial logistic regression models for NGAL and MMP-9 for staging, grading, and lymph node metastasis.

Protein	OR	95% CI
	Lymph node metastasis
NGAL	1.4	0.9–2.98	0.02
MMP-9	2.02	3.1–6.42	0.004
	FIGO III and IV versus I and II
NGAL	3.66	4.2–12.3	0.005
MMP-9	1.28	1.58–7.2	0.03
	GRADING III versus I
NGAL	1.09	1.8–5.2	0.03
MMP-9	1.83	2.4–8.9	0.02